SCHEMBL29392005

SCHEMBL29392005

CC(C)[C@H](N)C(=O)N[C@@H](CCCN)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.47
▸ DPP4 P27487 2/20 0.45
▸ DPP8 Q6V1X1 2/20 0.45
▸ DPP9 Q86TI2 2/20 0.45
▸ DPP7 Q9UHL4 2/20 0.45
▸ CPB2 Q96IY4 5/20 0.44
▸ NOD1 Q9Y239 1/20 0.44
▸ FAP Q12884 1/20 0.43
▸ GNPAT O15228 1/20 0.42
▸ SLC6A5 Q9Y345 1/20 0.41
▸ SLC7A5 Q01650 1/20 0.41
▸ ERAP2 Q6P179 1/20 0.40
▸ ERAP1 Q9NZ08 1/20 0.40
▸ LNPEP Q9UIQ6 1/20 0.40
▸ GSR P00390 1/20 0.39
▸ ECE1 P42892 1/20 0.39
▸ ACE P12821 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1711315 0.95 FOLH1 (0.54) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL29358709 0.95 FOLH1 (0.54) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL29358689 0.95 FOLH1 (0.54) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL29357446 0.95 FOLH1 (0.54) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL1711313 0.95 FOLH1 (0.54) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL29782763 0.92 FOLH1 (0.51) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL16862515 0.90 FOLH1 (0.49) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL16862514 0.90 FOLH1 (0.49) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL30578949 0.88 FOLH1 (0.48) FOLH1DPP4DPP8DPP9DPP7
SCHEMBL30093154 0.88 FOLH1 (0.48) FOLH1DPP4DPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022199237-A1 MODIFIED AMINO ACIDS AND APPLICATION THEREOF IN ADC 联宁(苏州)生物制药有限公司 2022-09-29 — — WO claimed
CN-114106088-A Bromomethylpyrazine-based drug conjugates and ADCs 联宁(苏州)生物制药有限公司 2022-03-01 — — CN claimed
CN-113816990-B Modified amino acids and their use in ADCs 联宁(苏州)生物制药有限公司 2023-08-22 — — CN disclosed
WO-2022199237-A1 MODIFIED AMINO ACIDS AND APPLICATION THEREOF IN ADC 联宁(苏州)生物制药有限公司 2022-09-29 — — WO disclosed
CN-114106088-A Bromomethylpyrazine-based drug conjugates and ADCs 联宁(苏州)生物制药有限公司 2022-03-01 — — CN disclosed
Send feedback